Literature DB >> 9192234

Removal of endogenous leptin from the circulation by the kidney.

F Cumin1, H P Baum, M de Gasparo, N Levens.   

Abstract

OBJECTIVE: This study was performed to test the hypothesis that the kidneys play a primary role in the clearance of endogenous leptin from the circulation of obese rats.
DESIGN: Zucker (fa/fa) obese rats were anaesthetized and subjected to various surgical manipulations of the kidneys. One hour after surgery arterial blood samples were taken at 1 h intervals for times upto 8 h. Plasma leptin concentrations were determined by radioimmunoassay.
RESULTS: Bilateral nephrectomy induced a rapid increase in plasma leptin concentrations above control values. In contrast, continuous intravenous re-injection of voided urine did not increase circulating leptin concentrations, indicating that leptin is not present in the urine in large quantities. This conclusion was confirmed by the very low levels of detectable leptin in urine. Leptin is not metabolized across the renal circulation and is extracted intact by the kidney. Simultaneous measurement of renal plasma flow established renal leptin extraction at approximately 59 ng/ min for both kidneys. Following intravenous infusion of leptin, renal clearance and whole body clearance were equal. This finding indicates that the kidneys alone are responsible for the systemic elimination of leptin in Zucker rats. Seven hours after bilateral ureteral ligation, a procedure which lowers glomerular filtration, plasma leptin concentrations were elevated. The renal extraction of leptin did not change over a wide range of plasma leptin concentrations suggesting that renal leptin extraction is a high capacity, non-saturable process most probably glomerular filtration.
CONCLUSION: Endogenous leptin is rapidly cleared from the circulation by the kidney by glomerular filtration followed by metabolic degradation in the renal tubules.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192234     DOI: 10.1038/sj.ijo.0800428

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  10 in total

1.  Correlates of leptin in children with chronic kidney disease.

Authors:  Edward Nehus; Susan Furth; Bradley Warady; Mark Mitsnefes
Journal:  J Pediatr       Date:  2014-07-25       Impact factor: 4.406

2.  Impact of uremia on human adipose tissue phenotype.

Authors:  Karen J Ho; Hui Xue; Christine R Mauro; Binh Nguyen; Peng Yu; Ming Tao; Michael A Seidman; Steven M Brunelli; Charles Keith Ozaki
Journal:  J Surg Res       Date:  2012-09-06       Impact factor: 2.192

3.  Resistin as a potential marker of renal disease in lupus nephritis.

Authors:  J Hutcheson; Y Ye; J Han; C Arriens; R Saxena; Q-Z Li; C Mohan; T Wu
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

4.  Leptin and ghrelin in chronic kidney disease: their associations with protein-energy wasting.

Authors:  Nur Canpolat; Lale Sever; Ayse Agbas; Mehmet Tasdemir; Cigdem Oruc; Ozlem Balcı Ekmekci; Salim Caliskan
Journal:  Pediatr Nephrol       Date:  2018-07-06       Impact factor: 3.714

Review 5.  Ghrelin and leptin pathophysiology in chronic kidney disease.

Authors:  Sujana S Gunta; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2012-12-11       Impact factor: 3.714

Review 6.  Intracellular signalling pathways activated by leptin.

Authors:  Gema Frühbeck
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

7.  Obesity hypertension: the regulatory role of leptin.

Authors:  Shilpa Kshatriya; Kan Liu; Ali Salah; Tamas Szombathy; Ronald H Freeman; Garry P Reams; Robert M Spear; Daniel Villarreal
Journal:  Int J Hypertens       Date:  2011-01-03       Impact factor: 2.420

Review 8.  Pathophysiology of Non Alcoholic Fatty Liver Disease.

Authors:  Salvatore Petta; Amalia Gastaldelli; Eleni Rebelos; Elisabetta Bugianesi; Piergiorgio Messa; Luca Miele; Gianluca Svegliati-Baroni; Luca Valenti; Ferruccio Bonino
Journal:  Int J Mol Sci       Date:  2016-12-11       Impact factor: 5.923

9.  The relationship between renal function and plasma concentration of the cachectic factor zinc-alpha2-glycoprotein (ZAG) in adult patients with chronic kidney disease.

Authors:  Caroline C Pelletier; Laetitia Koppe; Pascaline M Alix; Emilie Kalbacher; Marine L Croze; Aoumeur Hadj-Aissa; Denis Fouque; Fitsum Guebre-Egziabher; Christophe O Soulage
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

10.  Novel Role of Lck in Leptin-Induced Inflammation and Implications for Renal Aging.

Authors:  Dae Hyun Kim; June Whoun Park; Hyoung Oh Jeong; Bonggi Lee; Ki Wung Chung; Yujeong Lee; Hee Jin Jung; Min Kyung Hyun; A Kyoung Lee; Byeong Moo Kim; Byung Pal Yu; Hae Young Chung
Journal:  Aging Dis       Date:  2019-12-01       Impact factor: 6.745

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.